Abbott Alinity m System Software Issue Recall: Field Service Maintenance Risk
Abbott recalls Alinity m System model 08N53-002 due to software issues affecting field service maintenance procedures. Affected units may require specific software updates to prevent improper maintenance.
Lower-risk recall
There is a software issue associated with the ability to properly complete a Field Service Engineer Maintenance and Diagnostics procedure.
Contact the company
What happened, in plain English
Abbott is recalling the Alinity m System model 08N53-002 because of a software issue that could prevent proper field service maintenance. This means the system might not be maintained correctly, potentially leading to operational problems. Read more at govinfonow.com/recall/61468-abbott-alinity-m-system-software-issue-recall-field-service-maintenance.
Source Summary by GovInfoNow · govinfonow.com/recall/61468-abbott-alinity-m-system-software-issue-recall-field-service-maintenance · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0461-2022
Cite this page
“Abbott Alinity m System Software Issue Recall: Field Service Maintenance Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/61468-abbott-alinity-m-system-software-issue-recall-field-service-maintenance. Based on FDA recall #Z-0461-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0461-2022%22&limit=1).
Why it’s dangerous
The software issue prevents the system from completing field service maintenance and diagnostics procedures correctly. This could lead to improper maintenance, but it does not cause immediate injury or damage under normal use conditions.
Who’s affected
Users of the Alinity m System model 08N53-002 are affected. Laboratory technicians and healthcare facilities that use this system for testing are most at risk.
How to tell if you have this one
Check for the model number 08N53-002 or serial numbers on the Alinity m System. The product was sold by Abbott Molecular, Inc. starting from the date of manufacture.
- Brand
Abbott Molecular- Category
Medical device
What to do — step by step
Check Software Version
Verify the software version on the Alinity m System to ensure it is updated to the latest version compatible with field service procedures.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
FDA distribution: “Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belgium, Brazil, Cambodia, Canada, Chile, Colombia, Czech Republic, Egypt, El Salvador, Estonia, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy,…” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA published this recall 37 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-0461-2022 (December 6, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0461-2022 to see it in context.
- Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.